Bessemer Group Inc Biogen Inc. Transaction History

Bessemer Group Inc

$56.7 Billion
Q2 2024

A detailed history of Bessemer Group Inc transactions in Biogen Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 3,331 shares of BIIB stock, worth $651,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,331

Previous 3,054 9.07%

Holding current value

$651,643

Previous $657,000 17.5%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $52,774 - $65,571	277 Added 9.07%	3,331 $772,000
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $9,116 - $11,511	43 Added 1.43%	3,054 $657,000
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $457,422 - $550,616	-2,055 Reduced 40.56%	3,011 $779,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $84,348 - $95,201	-333 Reduced 6.17%	5,066 $1.3 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $292,866 - $338,415	1,064 Added 24.54%	5,399 $1.54 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $14,110 - $16,078	-55 Reduced 1.25%	4,335 $1.21 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $42,914 - $52,142	-170 Reduced 3.73%	4,390 $1.22 Million
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $171,911 - $237,050	883 Added 24.01%	4,560 $1.22 Million
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $1,875 - $2,230	-10 Reduced 0.27%	3,677 $750,000
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $165,479 - $208,495	854 Added 30.14%	3,687 $777,000
Q4 2021 Jan 27, 2022	BUY	$223.92 - $287.77 $155,624 - $200,000	695 Added 32.51%	2,833 $679,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $77,256 - $100,750	-273 Reduced 11.32%	2,138 $606,000
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $67,081 - $107,409	259 Added 12.04%	2,411 $834,000
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $447,999 - $524,857	-1,844 Reduced 46.15%	2,152 $602,000
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $209,562 - $315,443	-887 Reduced 18.17%	3,996 $978,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $802,253 - $926,301	-3,030 Reduced 38.29%	4,883 $1.39 Million
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $1.06 Million - $1.4 Million	4,081 Added 106.5%	7,913 $2.12 Million
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $72,320 - $91,739	-269 Reduced 6.56%	3,832 $1.21 Million
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $106,068 - $146,561	482 Added 13.32%	4,101 $1.22 Million
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $41,313 - $46,337	-190 Reduced 4.99%	3,619 $843,000
Q2 2019 Jul 19, 2019	BUY	$219.29 - $241.72 $355,688 - $392,069	1,622 Added 74.17%	3,809 $891,000
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $185,070 - $289,471	854 Added 64.07%	2,187 $518,000
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $106,108 - $134,397	381 Added 40.02%	1,333 $401,000
Q3 2018 Nov 06, 2018	SELL	$293.51 - $383.83 $11,740 - $15,353	-40 Reduced 4.03%	952 $336,000
Q2 2018 Jul 25, 2018	SELL	$257.52 - $306.91 $20,601 - $24,552	-80 Reduced 7.46%	992 $288,000
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $4,942 - $6,990	-19 Reduced 1.74%	1,072 $293,000
Q4 2017 Jan 30, 2018	BUY	$307.64 - $344.58 $10,152 - $11,371	33 Added 3.12%	1,091 $347,000
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $297,456 - $348,812	1,058	1,058 $331,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Biogen Inc. Transaction History